Re: AGM/rumour mill?'s
|
4
|
Zenith Epigenetics
|
Oct 27, 2021 04:11PM
|
Re: Alberta
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 11:10AM
|
Re: Almost 1.25 years now
|
5
|
Zenith Epigenetics
|
May 30, 2018 04:39PM
|
Re: Almost 1.25 years now
|
3
|
Zenith Epigenetics
|
May 31, 2018 04:05PM
|
Re: Amarin CEO interview
|
3
|
Resverlogix Corp.
|
Nov 12, 2018 02:50PM
|
Re: Amarin CEO interview - New class action lawsuit
|
4
|
Resverlogix Corp.
|
Nov 14, 2018 04:31PM
|
Re: Amazing....when the PPS climbs from $1.30 to near $2.50.....
|
5
|
Resverlogix Corp.
|
Dec 14, 2017 10:02AM
|
Re: American Society of Nephrology Kidney Week
|
4
|
Resverlogix Corp.
|
Nov 04, 2017 12:36PM
|
Re: American Society of Nephrology Kidney Week
|
3
|
Resverlogix Corp.
|
Nov 04, 2017 04:14PM
|
Re: Anacetrapib Officially Bites the Dust
|
6
|
Resverlogix Corp.
|
Oct 26, 2017 05:08PM
|
Re: Anacetrapib Officially Bites the Dust
|
5
|
Resverlogix Corp.
|
Oct 26, 2017 03:09PM
|
Re: And there's the news, 3 month loan extension....
|
4
|
Resverlogix Corp.
|
May 04, 2019 02:14PM
|
Re: And we wait.....
|
5
|
Zenith Epigenetics
|
Jan 31, 2018 05:26PM
|
Re: And we wait.....
|
3
|
Zenith Epigenetics
|
Jan 26, 2018 12:11PM
|
Re: Another article. Mechanism related.
|
9
|
Resverlogix Corp.
|
Jun 14, 2022 01:23PM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
4
|
Resverlogix Corp.
|
Dec 09, 2015 03:32PM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Dec 10, 2015 08:35AM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
3
|
Resverlogix Corp.
|
Dec 10, 2015 04:48PM
|
Re: Another Exempt Distribution -2022-06-02
|
7
|
Resverlogix Corp.
|
Jun 08, 2022 11:33AM
|
Re: Another Exempt Distribution -2022-06-02
|
4
|
Resverlogix Corp.
|
Jun 05, 2022 01:12PM
|